Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • polsum
    Member
    • May 2009
    • 32

    #1

    edgeR Normalization question

    The edgeR manual gives us three examples for DE analysis with each example normalizing the data in different manner.

    In the case study 1, the Normalization was done by calcNormFactors. In the case study 2 however, only counts per million or cpm was calculated and no calcNormFactors was used. In the case study 3, both cpm and calcNormFactors was used. In this 3rd example, we are essentially modifying the data two times before performing DE analysis which is strange to me.

    I basically want to perform miRNA DE analysis between two samples (each with 3 replicates). Which of the above methods is applicable for me?

    Can any one please educate me? thanks in advance.
  • Gordon Smyth
    Member
    • Apr 2011
    • 91

    #2
    Dear polsum,

    The edgeR User's Guide contains five case studies, and all are normalized exactly the same way, except for the second which deals with deepSAGE data for which simple library size normalization was considered sufficient.

    You are mis-understanding the role of cpm, which are used only as descriptive quantities for data exploration in edgeR, not as part of the formal normalization or differential expression process.

    We obviously recommend, unless there are good reasons otherwise, that you use calcNormFactors() for an RNA-Seq analysis.

    Note that edgeR is a Bioconductor package, so the way to get a prompt answer is to post your question to the Bioconductor mailing list. See the section "how to get help" in the edgeR User's Guide.

    It also seems that your version of edgeR must be very old. Could I suggest that you update?

    Gordon

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM
    • SEQadmin2
      New Genomics Technologies Take Aim at Long-Standing Limits
      by SEQadmin2


      Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

      We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
      ...
      09-28-2026, 10:25 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, Yesterday, 11:13 AM
    0 responses
    16 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, Yesterday, 10:48 AM
    0 responses
    17 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-15-2026, 10:52 AM
    0 responses
    35 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-14-2026, 05:39 AM
    0 responses
    42 views
    0 reactions
    Last Post SEQadmin2  
    Working...